A Phase 1 trial of the histone deacetylase inhibitor AR-42 in patients with neurofibromatosis type 2-associated tumors and advanced solid malignancies

Yazar: Collier, Katharine A., Valencia, Hugo, Newton, Herbert, Hade, Erinn M., Sborov, Douglas W., Cavaliere, Robert, Poi, Ming, Phelps, Mitch A., Liva, Sophia G., Coss, Christopher C., Wang, Jiang, Khountham, Soun, Monk, Paul, Shapiro, Charles L., Piekarz, Richard, Hofmeister, Craig C., Bradley Welling, D., Mortazavi, Amir
Yayımlandı Cancer Chemother Pharmacol (2021)

Open access: Is there a predator at the door?

Yazar: Chandra, Rakesh, Fisher, Edward W., Jones, Terry M., Kennedy, David W., Kraus, Dennis H., Krouse, John H., Link, Michael, Lustig, Lawrence R., O'Malley, Bert W., Piccirillo, Jay F., Ruben, Robert, Sataloff, Robert T., Sindwani, Raj, Smith, Richard J., Stewart, Michael G., Weber, Peter C., Bradley Welling, D., Youngs, Robin
Yayımlandı Laryngoscope Investig Otolaryngol (2018)